Bromocriptine for the treatment of peripartum cardiomyopathy - Multicenter proof of concept study - Discussion.

29 April 2017 (08:37 - 08:40)

Organised by:

Video

Sign in for access options

10 More presentations in this session

Presentation thumbnail

Bromocriptine for the treatment of peripartum cardiomyopathy - Multicenter proof of concept study.

Professor D. Hilfiker-Kleiner (Hannover, DE)

Presentation thumbnail

Safety and efficacy of low dose intracoronary insulin-like growth factor 1 to prevent heart failure following percutaneous coronary intervention for acute myocardial infarction (RESUS-AMI).

Professor N. Caplice (Cork, IE)

Presentation thumbnail

Discussion: RESUS-AMI.

Presentation thumbnail

Relationship between baseline systolic blood pressure and long term outcomes in acute heart failure patients treated with TRV027: an exploratory subgroup analysis of BLAST-AHF.

Doctor G. cotter (Durham, US)

Presentation thumbnail

Discussion: BLAST-AHF.

Access the full session

Session thumbnail

Late Breaking Trials I: Focus on acute heart failure

The Event

Heart Failure 2017 - 4th World Congress on Acute Heart Failure

29 April 2017 08:37 CET

You may be interested in

Congress Presentation

Bromocriptine treatment and outcome in patients with peripartum cardiomyopathy: the EORP PPCM registry

2 September 2024

Congress Presentation

Peripartum cardiomyopathy

21 May 2023

Congress Presentation

Ventricular arrhythmias in patients with peripartum cardiomyopathy depending on the level of prolactin

23 May 2023

Congress Session

Heart failure in young women

17 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources